This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Kaizhang He, Ph.D.
Director of Process Chemistry at Agilent Technologies
Speaker

Profile

Kai is a process chemistry and development leader with extensive experience in developing products and processes for nucleic acids (nucleosides, phosphoramidites, nucleotides, and oligonucleotides) ranging from research, process development, and process validation. He has over 15 years of experience leading product and process development teams with past employers that include Thermo Fisher Scientific, GE Healthcare, and WuXi AppTec. Kai received a B.S. degree in chemistry from Tsinghua University in China, and his Ph.D. in organic chemistry from Duke University.

Agenda Sessions

  • Important Aspects to Successful Manufacturing Outcomes Through Agilent’s Six Years of Making GMP sgRNA

    2:40pm